Indomethacin and Metastases to lymph nodes - a phase IV clinical study of FDA data

Summary:

Metastases to lymph nodes is reported as a side effect among people who take Indomethacin (indomethacin), especially for people who are male, 50-59 old, also take Zometa, and have Osteoporosis.

The phase IV clinical study analyzes which people have Metastases to lymph nodes when taking Indomethacin. It is created by eHealthMe based on reports of 16,214 people who have side effects when taking Indomethacin from the FDA, and is updated regularly.

What is Indomethacin?

Indomethacin has active ingredients of indomethacin. It is often used in gout. eHealthMe is studying from 16,884 Indomethacin users. Check the latest studies of Indomethacin.

What is Metastases to lymph nodes?

Metastases to lymph nodes (cancer spreads to lymph node) is found to be associated with 670 drugs and 789 conditions by eHealthMe. Check the latest studies of Metastases to lymph nodes.

On Jul, 31, 2026

16,214 people reported to have side effects when taking Indomethacin.
Among them, 13 people (0.08%) have Metastases to lymph nodes.

Could Indomethacin cause Metastases to lymph nodes?

Among these 13 people:

What is the gender of people who have Metastases to lymph nodes when taking Indomethacin? *

female: 8.33 %
male: 91.67 %

What is the age of people who have Metastases to lymph nodes when taking Indomethacin? *

What are other drugs people take besides Indomethacin? *

What are other side effects people have besides Metastases to lymph nodes? *

Swelling: 10 people, 76.92%
Spinal Osteoarthritis (joint cartilage loss in spine): 10 people, 76.92%
Weakness: 10 people, 76.92%
Metastases To Bone (cancer spreads to bone): 10 people, 76.92%
Neoplasm Malignant (cancer tumour): 10 people, 76.92%
Bone Pain: 10 people, 76.92%
Intervertebral Disc Protrusion (spinal disc protrusion): 10 people, 76.92%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 10 people, 76.92%
Osteonecrosis Of Jaw (death of bone of jaw): 10 people, 76.92%
Pain: 10 people, 76.92%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 6 people, 46.15%
Prostate Cancer Metastatic: 5 people, 38.46%
Metastases To Bone (cancer spreads to bone): 5 people, 38.46%
Cuts And Puncture Wounds: 4 people, 30.77%
Metastases To Prostate (cancer spreads to prostate): 1 person, 7.69%
Cancer Pain: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Indomethacin and have Metastases to lymph nodes?

- Check whether Metastases to lymph nodes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Indomethacin:

Indomethacin (16,884 reports)

Browse all side effects of Indomethacin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Metastases to lymph nodes:

Metastases to lymph nodes (670 drugs)

Browse all the conditions that are associated with Metastases to lymph nodes:

Metastases to lymph nodes (789 conditions)

Related publications that referenced our studies

Mantarro S, Tuccori M, Pasqualetti G, Tognini S, Montagnani S, Monzani F, Blandizzi C, "Acute portal vein thrombosis precipitated by indomethacin in a HCV-positive elderly patient", BMC geriatrics, 2012 Nov .
Mantarro S, Tuccori M, Pasqualetti G, Tognini S, Montagnani S, Monzani F, Blandizzi C, "Acute portal vein thrombosis precipitated by indomethacin in a HCV-positive elderly patient", BMC geriatrics, 2012 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on indomethacin (the active ingredients of Indomethacin) and Indomethacin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.